Bhupal Ban, PhD
Senior Staff Scientist, Pharmaceutical Biotechnology Center
Bhupal Ban, Ph.D., joined the IBRI in March 2019 as Senior Staff Scientist in the IBRI’s Pharmaceutical Biotechnology Center (PBC). In this role, he will be responsible for defining and executing molecular engineering strategies designed to optimize the biological activity and pharmaceutical properties of lead monoclonal antibody candidates.
Prior to the IBRI, and since 2015, Dr. Ban served as an Assistant Professor of Research and Director of the Antibody and Engineering Technology Core in the Department of Cell Biology at the University of Virginia in Charlottesville, Va. While at UVA, he was recognized as having the outstanding research core of the year for 2016. Prior to UVA and since 2013, he served as Research Associate in the College of Pharmacy at Xavier University in New Orleans, La. From 2011 to 2013, he was a Postdoctoral Researcher at Tulane University’s School of Medicine, also in New Orleans.
Dr. Ban’s corporate experience includes working in the Bioscience Division of Los Alamos National Laboratory in Los Alamos, N.M., and serving as Senior Research Scientist and Project Leader for MedyTox Inc. in South Korea where he was recognized as outstanding researcher of the year in 2008.
A native of Nepal, Dr. Ban earned his B.S. in Biological Sciences from Tri-bhuvan University in Nepal, and his M.S. in Organic Chemistry, also from Tri-bhuvan University. He earned his Ph.D. in Biochemistry from Sun Moon University in South Korea, where he also served as a Doctoral Researcher. He has published more than two dozen papers and presentation abstracts and holds three patents.